CIBC Private Wealth Group
GUTS icon

CIBC Private Wealth Group’s Fractyl Health GUTS Stock Holding History

CIBC Private Wealth Group’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.64K Buy
+1,200
New +$1.93K ﹤0.01% 2758

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

CIBC Private Wealth Group's GUTS Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Fractyl Health (GUTS) in Q4 2025: 1,200 shares worth $2.64K. The stake represents ﹤0.01% of the portfolio and ranks #2758 among its holdings.

97 funds tracked by Wall St. Rank hold GUTS as of Q4 2025.

  • CIBC Private Wealth Group held 1,200 shares of Fractyl Health worth $2.64K as of Q4 2025.
  • Fractyl Health was a new CIBC Private Wealth Group position in Q4 2025.
  • Fractyl Health made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2758 holding.
  • 97 funds tracked by Wall St. Rank held Fractyl Health as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.